Table 1 Demographic and clinical characteristics of the ACS patients and CG individuals.
Demographic characteristic | CG, n (%) | ACS group, n (%) | p |
|---|---|---|---|
Cardiovascular risk factor | |||
Age (median, IQR) | 57 (51–63) | 64 (57–70) | < 0.0001 |
Male | 143 (48) | 215 (72) | < 0.0001 |
Female | 157 (52) | 85 (28) | < 0.0001 |
High blood pressure | 100 (33) | 214 (71) | < 0.0001 |
Dyslipidemia | 65 (22) | 148 (49) | < 0.0001 |
T2DM | 65 (22) | 172 (57) | < 0.0001 |
Smoking | 66 (22) | 143 (48) | < 0.0001 |
Overweight | 85 (28) | 116 (39) | 0.0043 |
Obesity | 81 (18) | 80 (27) | 0.0084 |
Sedentary lifestyle | 88 (29) | 181 (60) | < 0.0001 |
Reinfarction | – | 53 (18) | – |
Medication | |||
ASA | 3 (1) | 287 (96) | < 0.0001 |
Clopidogrel | – | (92) | – |
Metformin | 18 (6) | 21 (7) | 0.6196 |
Insulin | – | 12 (4) | – |
Antihypertensive | 11 (4) | 61 (20) | < 0.0001 |
Statin | 21 (3) | 285 (95) | < 0.0001 |
Bezafibrate | 5 (2) | 8 (3) | 0.6043 |
Losartan | 21 (7) | 54 (18) | < 0.0001 |
β-blocker | 6 (2) | 180 (60) | < 0.0001 |
Enalapril | 6 (2) | 135 (45) | < 0.0001 |
Captopril | – | 51 (17) | – |
Isosorbide | – | 72 (24) | – |
Amlodipine | 46 (12) | 30 (10) | 0.4341 |
Heparin | – | 42 (14) | – |
Enoxaparin | – | 201 (67) | – |
